Thierry Ziegler

Thierry Ziegler has more than 25 years of experience in biopharmaceutical development. Prior to joining Igyxos, he led cell therapy production activities at Cellectis. Previously, Dr. Ziegler also served as Head of Process Development at Merck-Serono, as well as head of biopharmaceutical development at Sanofi. During his career, he had the opportunity to work on multiple monoclonal antibodies as well as many other types of Biologics modalities ranging from recombinant proteins to CAR-T cells. He joined Igyxos in February 2021 as Chief Operating Officer to oversee subcontracted activities related to the development of IGX12. In this role, Dr. Ziegler oversees IGX12 CMC development from cell line generation to GMP manufacturing. He received his Ph.D. in bioprocess engineering from the Georgia Institute of Technology in the United States.